Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 207


C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

Schlick K, Magnes T, Huemer F, Ratzinger L, Weiss L, Pichler M, Melchardt T, Greil R, Egle A.

J Clin Med. 2019 Oct 25;8(11). pii: E1791. doi: 10.3390/jcm8111791.


Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.

Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M.

Cancers (Basel). 2019 Oct 17;11(10). pii: E1580. doi: 10.3390/cancers11101580. Review.


Current concepts of non-coding RNA regulation of immune checkpoints in cancer.

Smolle MA, Prinz F, Calin GA, Pichler M.

Mol Aspects Med. 2019 Dec;70:117-126. doi: 10.1016/j.mam.2019.09.007. Epub 2019 Sep 30. Review.


Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.


The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.

Smolle E, Fink-Neuboeck N, Lindenmann J, Smolle-Juettner F, Pichler M.

Cancers (Basel). 2019 Aug 6;11(8). pii: E1118. doi: 10.3390/cancers11081118. Review.


The Non-Coding RNA Journal Club: Highlights on Recent Papers-7.

Xiao H, Shiu PKT, Gabryleska M, Conn SJ, Dey A, Chakrabarti K, Regouc M, Pichler M, Ørom UAV, Santulli G, Nishiwada S, Goel A, Nagarajan V, Timmons L, Alahari SK, Laprovitera N, Ferracin M, Hu P, Jin H.

Noncoding RNA. 2019 Jun 11;5(2). pii: E40. doi: 10.3390/ncrna5020040.


BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.

Hutterer GC, Posch F, Buser L, Zigeuner R, Morshäuser L, Otto W, Wild PJ, Burger M, May M, Pichler M, Brookman-May SD.

Urol Oncol. 2019 Jul;37(7):510-518. doi: 10.1016/j.urolonc.2019.04.004. Epub 2019 May 3.


Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F.

Sci Rep. 2019 Apr 3;9(1):5548. doi: 10.1038/s41598-019-42069-1.


Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?

Pichler R, Compérat E, Klatte T, Pichler M, Loidl W, Lusuardi L, Schmidinger M.

Cancers (Basel). 2019 Mar 25;11(3). pii: E422. doi: 10.3390/cancers11030422.


Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.

J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15.


Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.

Richtig G, Aigelsreiter AM, Asslaber M, Weiland T, Pichler M, Eberhard K, Sygulla S, Schauer S, Hoefler G, Aigelsreiter A.

Histopathology. 2019 Jul;75(1):118-127. doi: 10.1111/his.13860. Epub 2019 May 28.


The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.

Prinz F, Kapeller A, Pichler M, Klec C.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E627. doi: 10.3390/ijms20030627. Review.


MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.


High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.

Pichler R, Loidl W, Pichler M.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S738-S740. doi: 10.21037/tau.2018.08.15. No abstract available.


Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.

Klec C, Gutschner T, Panzitt K, Pichler M.

Expert Opin Ther Targets. 2019 Mar;23(3):177-186. doi: 10.1080/14728222.2019.1570499. Epub 2019 Jan 24.


Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer-the more specific, the better?

Smolle E, Pichler M.

J Thorac Dis. 2018 Nov;10(Suppl 33):S3961-S3964. doi: 10.21037/jtd.2018.09.81. No abstract available.


Involvement of the long noncoding RNA NEAT1 in carcinogenesis.

Klec C, Prinz F, Pichler M.

Mol Oncol. 2019 Jan;13(1):46-60. doi: 10.1002/1878-0261.12404. Epub 2018 Dec 3. Review.


Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.

Foßelteder J, Calin GA, Pichler M.

Expert Opin Ther Targets. 2018 Dec;22(12):973-976. doi: 10.1080/14728222.2018.1541453. Epub 2018 Oct 30. No abstract available.


MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

Supplemental Content

Loading ...
Support Center